GlaxoSmithKline UK

Stockley Park West, Uxbridge, Middlesex, UB11 1BT
Telephone: +44 (0)800 221 441
Fax: +44 (0)208 990 4328
Medical Information e-mail: customercontactuk@gsk.com

Patient Information Leaflet last updated on the eMC: 17/01/2012
PIL Pandemrix suspension and emulsion for emulsion for injection

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 17/01/2012 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
Updated on 30/09/2011 and displayed until 17/01/2012
Reasons for adding or updating:
  • Change to date of revision
  • Change to, or new, use for medicine
  • Change to side-effects
Updated on 21/02/2011 and displayed until 30/09/2011
Reasons for adding or updating:
  • Change/addition of instructions for reconstitution and/ or administration
  • Correction of spelling/typing errors
Updated on 20/09/2010 and displayed until 21/02/2011
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
  • Change to side-effects
Updated on 20/08/2010 and displayed until 20/09/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to, or new, use for medicine
  • Change to warnings or special precautions for use
Updated on 10/03/2010 and displayed until 20/08/2010
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 05/03/2010 and displayed until 10/03/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
Updated on 26/01/2010 and displayed until 05/03/2010
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 26/01/2010 and displayed until 26/01/2010
Reasons for adding or updating:
  • Improved Electronic Presentation
  • Change to date of revision
Updated on 26/10/2009 and displayed until 26/01/2010
Reasons for adding or updating:
  • New PIL for new product
  • PIL Retired pending re-submission

Active Ingredients/Generics

 
   influenza vaccine (split virion, inactivated)